08:00 , Jan 19, 2009 |  BC Week In Review  |  Clinical News

PrepaCyte-CB regulatory update

FDA granted 510(k) clearance for BioE's PrepaCyte-CB processing system to separate and collect stem cells, total nucleating cells and white blood cells from umbilical cord blood. BioE Inc. , St. Paul, Minn.   Product: PrepaCyte-CB...
08:00 , Dec 3, 2007 |  BC Week In Review  |  Clinical News

PrepaCyte-CB regulatory update

BioE submitted a 510(k) application to FDA for its PrepaCyte-CB processing system for use in separating and collecting stem cells, total nucleating cells and white blood cells from umbilical cord blood. BioE Inc. , St....
07:00 , May 22, 2006 |  BC Week In Review  |  Company News

BioE board of directors update

BioE Inc. , St. Paul, Minn.   Business: Supply/Service, Gene/Cell therapy   Appointed: John Miller, medical director of the National Marrow Donor Program's Donor Medical Services  ...
07:00 , May 8, 2006 |  BC Week In Review  |  Company News

BioE management update

BioE Inc. , St. Paul, Minn.   Business: Supply/Service, Gene/Cell therapy   Hired: Gayl Chrysler as VP of cellular technologies and clinical affairs, formerly national director of operations for the National American Red Cross' cord...
08:00 , Nov 7, 2005 |  BC Week In Review  |  Company News

BioE board of directors update

BioE Inc. , St. Paul, Minn.   Business: Supply/Service, Gene/Cell therapy   Appointed: Ronald Erickson, chairman and CEO of Holiday Cos. Inc.  ...
07:00 , Oct 17, 2005 |  BC Week In Review  |  Company News

BioE management update

BioE Inc. , St. Paul, Minn.   Business: Gene/Cell therapy   Hired: Sarah Haecker as VP of corporate development, formerly a principal at Andcor Companies Inc.  ...
07:00 , May 9, 2005 |  BC Week In Review  |  Company News

BioE sales and marketing update

BioE launched clonal stem cell lines for research use. The cell lines are derived from human umbilical cord blood. BioE Inc. , St. Paul, Minn.   Business: Supply/Service  ...
08:00 , Mar 29, 2004 |  BC Week In Review  |  Company News

BioE, University of Southern California deal

BioE and the university partnered to research and develop umbilical cord stem cell therapies for neurodegenerative diseases, including multiple sclerosis (MS), Parkinson's disease (PD), spinal cord injury (SCI), amyotrophic lateral sclerosis (ALS) and stroke. BioE...
08:00 , Nov 3, 2003 |  BC Week In Review  |  Company News

BioE, Biovest deal

BioVest will manufacture antibodies for BioE's stem cell isolation system. Under the deal, BioE will provide cell lines to BioVest. BioVest will in turn optimize growth and antibody production using its Acusyst-X-Cell hollow fiber bioreactor....